FAM46C as a Potential Marker for Pan-Cancer Prognosis and Predicting Immunotherapeutic Efficacy
Background:FAM46C is a common mutated gene in tumours. A comprehensive understanding of the relationship between FAM46C expression and pan-cancer can guide clinical prognosis and broaden the immunotherapeutic targets.Methods: Data from The Cancer Genome Atlas and Genotype-Tissue Expression (GTEx) da...
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado: |
Frontiers Media S.A.
2022-02-01
|
| Series: | Frontiers in Genetics |
| Subjects: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fgene.2022.810252/full |